These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 37300293)

  • 41. Partial Improvement of Spatial Memory Damages by Bone Marrow Mesenchymal Stem Cells Transplantation Following Trimethyltin Chloride Administration in the Rat CA1.
    Madadi S; Katebi M; Eftekharzadeh M; Mehdipour A; Pourheydar B; Mehdizadeh M
    Basic Clin Neurosci; 2019; 10(6):567-577. PubMed ID: 32477474
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Mesenchymal stem cells augment neurogenesis in the subventricular zone and enhance differentiation of neural precursor cells into dopaminergic neurons in the substantia nigra of a parkinsonian model.
    Park HJ; Shin JY; Lee BR; Kim HO; Lee PH
    Cell Transplant; 2012; 21(8):1629-40. PubMed ID: 22546197
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Gemfibrozil Protects Dopaminergic Neurons in a Mouse Model of Parkinson's Disease via PPARα-Dependent Astrocytic GDNF Pathway.
    Gottschalk CG; Jana M; Roy A; Patel DR; Pahan K
    J Neurosci; 2021 Mar; 41(10):2287-2300. PubMed ID: 33514677
    [TBL] [Abstract][Full Text] [Related]  

  • 44. The expression change of glial fibrillary acidic protein and tyrosine hydroxylase in substantia nigra of the Wistar rats exposed to chlorpyrifos: a novel environmental risk factor for Parkinson's disease.
    Sheikh A; Sheikh K
    Exp Brain Res; 2020 Sep; 238(9):2041-2051. PubMed ID: 32632573
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Characterization of liraglutide, a glucagon-like peptide-1 (GLP-1) receptor agonist, in rat partial and full nigral 6-hydroxydopamine lesion models of Parkinson's disease.
    Hansen HH; Fabricius K; Barkholt P; Mikkelsen JD; Jelsing J; Pyke C; Knudsen LB; Vrang N
    Brain Res; 2016 Sep; 1646():354-365. PubMed ID: 27233809
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Brain-derived neurotrophic factor modified human umbilical cord mesenchymal stem cells-derived cholinergic-like neurons improve spatial learning and memory ability in Alzheimer's disease rats.
    Hu W; Feng Z; Xu J; Jiang Z; Feng M
    Brain Res; 2019 May; 1710():61-73. PubMed ID: 30586546
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Mesenchymal stem cell transplantation attenuates blood brain barrier damage and neuroinflammation and protects dopaminergic neurons against MPTP toxicity in the substantia nigra in a model of Parkinson's disease.
    Chao YX; He BP; Tay SS
    J Neuroimmunol; 2009 Nov; 216(1-2):39-50. PubMed ID: 19819031
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Trib3 Is Elevated in Parkinson's Disease and Mediates Death in Parkinson's Disease Models.
    Aimé P; Sun X; Zareen N; Rao A; Berman Z; Volpicelli-Daley L; Bernd P; Crary JF; Levy OA; Greene LA
    J Neurosci; 2015 Jul; 35(30):10731-49. PubMed ID: 26224857
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Analysis of morphological and neurochemical changes in subthalamic nucleus neurons in response to a unilateral 6-OHDA lesion of the substantia nigra in adult rats.
    Sedaghat K; Gundlach AL; Finkelstein DI
    IBRO Neurosci Rep; 2021 Jun; 10():96-103. PubMed ID: 33842916
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Effect of 6-hydroxydopamine treatment on kynurenine aminotransferase-I (KAT-I) immunoreactivity of neurons and glial cells in the rat substantia nigra.
    Knyihár-Csillik E; Chadaide Z; Mihály A; Krisztin-Péva B; Fenyo R; Vécsei L
    Acta Neuropathol; 2006 Aug; 112(2):127-37. PubMed ID: 16788821
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Neuron-derived IgG protects dopaminergic neurons from insult by 6-OHDA and activates microglia through the FcγR I and TLR4 pathways.
    Zhang J; Niu N; Wang M; McNutt MA; Zhang D; Zhang B; Lu S; Liu Y; Liu Z
    Int J Biochem Cell Biol; 2013 Aug; 45(8):1911-20. PubMed ID: 23791745
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Chronic, systemic treatment with a metabotropic glutamate receptor 5 antagonist in 6-hydroxydopamine partially lesioned rats reverses abnormal firing of dopaminergic neurons.
    Chen L; Zhang QJ; Liu J; Wang S; Ali U; Gui ZH; Wang Y
    Brain Res; 2009 Aug; 1286():192-200. PubMed ID: 19545547
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Physical exercise and human adipose-derived mesenchymal stem cells ameliorate motor disturbances in a male rat model of Parkinson's disease.
    Cucarián JD; Berrío JP; Rodrigues C; Zancan M; Wink MR; de Oliveira A
    J Neurosci Res; 2019 Sep; 97(9):1095-1109. PubMed ID: 31119788
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Up-regulated microRNA-218-5p ameliorates the damage of dopaminergic neurons in rats with Parkinson's disease via suppression of LASP1.
    Ma X; Zhang H; Yin H; Geng S; Liu Y; Liu C; Zhao J; Liu Y; Wang X; Wang Y
    Brain Res Bull; 2021 Jan; 166():92-101. PubMed ID: 33144090
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Intranasal administration of endometrial mesenchymal stem cells as a suitable approach for Parkinson's disease therapy.
    Bagheri-Mohammadi S; Alani B; Karimian M; Moradian-Tehrani R; Noureddini M
    Mol Biol Rep; 2019 Aug; 46(4):4293-4302. PubMed ID: 31123907
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Dopaminergic reinnervation of the globus pallidus by fetal nigral grafts in the rodent model of Parkinson's disease.
    Bartlett LE; Mendez I
    Cell Transplant; 2005; 14(2-3):119-27. PubMed ID: 15881421
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Acetyl-l-carnitine protects dopaminergic nigrostriatal pathway in 6-hydroxydopamine-induced model of Parkinson's disease in the rat.
    Afshin-Majd S; Bashiri K; Kiasalari Z; Baluchnejadmojarad T; Sedaghat R; Roghani M
    Biomed Pharmacother; 2017 May; 89():1-9. PubMed ID: 28199883
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Therapeutic potentials of plant iridoids in Alzheimer's and Parkinson's diseases: A review.
    Dinda B; Dinda M; Kulsi G; Chakraborty A; Dinda S
    Eur J Med Chem; 2019 May; 169():185-199. PubMed ID: 30877973
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Irisin protects the substantia nigra dopaminergic neurons in the rat model of Parkinson's disease.
    Zarbakhsh S; Safari M; Aldaghi MR; Sameni HR; Ghahari L; Khaleghi Lagmouj Y; Rahimi Jaberi K; Parsaie H
    Iran J Basic Med Sci; 2019 Jul; 22(7):722-728. PubMed ID: 32373292
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Reversal of dopaminergic degeneration in a parkinsonian rat following micrografting of human bone marrow-derived neural progenitors.
    Glavaski-Joksimovic A; Virag T; Chang QA; West NC; Mangatu TA; McGrogan MP; Dugich-Djordjevic M; Bohn MC
    Cell Transplant; 2009; 18(7):801-14. PubMed ID: 19796495
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.